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A bstract
Background: Shoulder disorders are a common health problem in western societies. Several treatm ent protocols have 
been developed fo r the clinical management o f persons w ith shoulder pain. However available evidence does not support 
any protocol as being superior over others. Systematic reviews provide some evidence that certain physical therapy 
interventions (i.e. supervised exercises and mobilisation) are effective in particular shoulder disorders (i.e. ro ta to r cuff 
disorders, mixed shoulder disorders and adhesive capsulitis), but there is an ongoing need fo r high quality trials o f physical 
therapy interventions. Usually, physical therapy consists o f active exercises intended to  strengthen the shoulder muscles 
as stabilizers o f the glenohumeral jo in t o r perform mobilisations to  improve restricted mobility o f the glenohumeral o r 
adjacent joints (shoulder girdle). It is generally accepted that a-traumatic shoulder problems are the result o f 
impingement o f the subacromial structures, such as the bursa o r ro ta to r cuff tendons. Myofascial trigger points (MTrPs) 
in shoulder muscles may also lead to  a complex o f symptoms that are often seen in patients diagnosed w ith subacromial 
impingement o r ro ta to r cuff tendinopathy. Little is known about the treatm ent o f MTrPs in patients w ith shoulder 
disorders.
The primary aim o f this study is to  investigate whether physical therapy modalities to  inactivate MTrPs can reduce 
symptoms and improve shoulder function in daily activities in a population o f chronic a-traumatic shoulder patients when 
compared to  a wait-and-see strategy. In addition we investigate the recurrence rate during a one-year-follow-up period.
Methods/Design: This paper presents the design fo r a randomized controlled tria l to  be conducted between 
September 2007 -  September 2008, evaluating the effectiveness o f a physical therapy treatm ent fo r non-traumatic 
shoulder complaints. One hundred subjects are included in this study. A ll subjects have unilateral shoulder pain fo r at 
least six months and are referred to  a physical therapy practice specialized in musculoskeletal disorders o f the neck-, 
shoulder-, and arm.
A fte r the initial assessment patients are randomly assigned to  either an intervention group o r a control-group (wait and 
see). The primary outcome measure is the overall score o f the Dutch language version o f the DASH (Disabilities o f Arm, 
Shoulder and Hand) questionnaire.
Discussion: Since there is only little evidence fo r the efficacy o f physical therapy interventions in certain shoulder 
disorders, there is a need fo r further research. W e found only a few studies examining the efficacy o f MTrP therapy fo r
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shoulder disorders. Therefore we w ill perform a randomised clinical tria l o f the effect o f physical therapy interventions 
aimed to  inactivate MTrPs, on pain and impairment in shoulder function in a population o f chronic a-traumatic shoulder 
patients. W e  opted fo r an intervention strategy that best reflects daily practice. Manual high velocity thrust techniques 
and dry-needling are excluded. Because in most physical therapy interventions, blinding o f the patient and the therapist 
is not possible, we w ill perform a randomised, controlled and observer-blinded study.
T ria l Registration: This randomized clinical tria l is registered at current controlled trials ISRCTN75722066.
Background
Shoulder pain is a common health problem in western 
societies. There are substantial differences in reported 
prevalence in the general population. The one-year preva­
lence of shoulder disorders has been reported to range 
from 20% to 50%. This wide range is strongly influenced 
for example by the definition of shoulder disorders, 
including or excluding limited motion, age, gender and 
anatomic area [1-3]. Of all shoulder patients who attend 
primary care physicians 50% recover within 6 months, 
meaning they do not seek any medical help after the first 
episode[1,4-6]. Chronicity and recurrence of symptoms 
are common [7,8]. According to the guidelines of the 
Dutch College of General Practioners [9], the recom­
mended management of shoulder symptoms starts with 
educational information about the natural course of 
shoulder pain combined with the advise to avoid irritat­
ing and loading activities. The use of analgesics or NSAIDs 
is recommended for the first two weeks. When no recov­
ery occurs within two weeks, subacromial or intra-articu- 
lar injection therapy with corticosteroids are administered 
and eventually repeated. Finally, physical therapy is only 
recommended after a 6-week period when there are func­
tional limitations (specifically an activating and time-con­
tingent approach). International guidelines for shoulder 
pain, including the Clinical Guideline of Shoulder pain of 
the American Academy of Orthopaedic Surgeons [10] and 
the Shoulder Guideline of the New Zealand Guidelines 
Group[11] differ more or less from the Dutch guidelines 
in classification, recommended interventions and time­
line, and order of interventions. Scientific evidence from 
randomized clinical trials, meta-analyses or systematic 
reviews for either the efficacy of multimodal rehabilita­
tion, injection therapy, medication, surgery or physical 
therapy or the order of application of commonly used 
therapies is lacking [12-16].
An alternative approach to the management of persons 
with shoulder problems consists of a treatment aimed at 
inactivating MTrPs and eliminating factors that perpetuate 
them. MTrPs may be inactivated by manual techniques 
(such as compression on the trigger point or other mas­
sage techniques), cooling the skin with ethyl chloride 
spray or with ice-cubes followed by stretching of the 
involved muscle, trigger point needling using an acupunc­
ture needle, or injection with local anaesthetics or Botuli­
num toxin, followed by ergonomic advises, active 
exercises, postural correction, and relaxation (with or 
without biofeedback)[17,18]. Over the years, MTrPs are 
increasingly accepted in the medical literature. Clinical, 
histological, biochemical and electrophysiological 
research has provided biological plausibility for the exist­
ence of MTrPs [19-24].
MTrPs are defined as exquisitely tender spots in discrete 
taut bands of hardened muscle that produce symptoms 
[25,26]. A previous study showed that MTrPs can be 
detected reliably by trained physiotherapists [27]. Palpa­
tion is still the only reliable method to diagnose myofas­
cial pain clinically. In reviews addressing the efficacy of 
interventions in shoulder patients, MTrP therapy and 
myofascial pain are rarely mentioned [15]. However, 
some published case studies suggest that treatment of 
MTrPs in shoulder patients may be beneficial [28-31].
The primary aim of this study is to investigate the effec­
tiveness of inactivation of MTrPs in shoulder muscles by 
physical therapy on symptoms and functioning of the 
shoulder in daily activities in a population of chronic a­
traumatic shoulder patients when compared to a wait- 
and-see strategy. In addition, we investigate the recurrence 
rate during a one-year-follow-up period.
Methods/Design
An examiner-blinded randomized controlled trial will be 
conducted, which has been approved by the ethics com­
mittee of the Radboud University Nijmegen Medical Cen­
tre, the Netherlands [CMO 2007/022].
Participants/Study sam ple
Between September 2007 and September 2008, all con­
secutive patients referred to a physical therapy practice 
specialized in the treatment of individuals with muscu­
loskeletal disorders of the neck, shoulder and arm are 
potential study participants. The referring physicians 
include general practioners, orthopaedic surgeons, neu­
rologists and physiatrists. Patients are eligible if they have 
unilateral shoulder complaints (described as pain felt in 
the shoulder or upper arm) for at least six months. The 
patients present with persistent shoulder pain that has not 
spontaneously recovered. The patients are between 18 and 
65 years old. Because the questionnaires are in the Dutch
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language, subjects must understand written and verbal 
Dutch. Patients who have been diagnosed (prior to the 
referral) with shoulder instability, shoulder fractures, sys­
temic diseases (such as rheumatoid arthritis, Reiter's syn­
drome, diabetes), or who's medical history or 
examination suggests neurological diseases, or other 
severe medical or psychiatric disorders will be excluded 
from the study. The project leader will check all the avail­
able information from referral letters, additional informa­
tion from the general practitioner and from the patients. 
All eligible patients will be informed of the study and will 
be invited to participate. Patients who are willing to par­
ticipate will be asked to review and sign the written 
informed consent.
M easurem ents
Before randomization, all participants will be assessed 
during an individual baseline test session. They will com­
plete a battery of questionnaires and tests, determining 
data on social, demographic, and physical factors, and 
baseline values for the outcome measures. In addition, 
subjects will complete the DASH, RAND-3 6-dutch lan­
guage version, and passive range of motion tests of the 
shoulder (PROM). During the initial assessment, MTrPs 
will be identified, based on compression-produced pain 
that is recognized by patients as their own shoulder pain. 
If no MTrPs are detected, the subjects will be excluded 
from the study. All measurements will be performed by 
the same independent observer, who is not employed by 
the physical therapy practice (This is to create optimal 
blinding of the observer, who is now not able to recognise 
the subjects). The observer is trained in identifying MTrPs 
and has several years of clinical experience in MTrP ther­
apy. The observer participated in a former reliability study 
of MTrP palpation. The baseline measurements will be at 
T0, the second measurement (T1) will be 6 weeks after the 
first assessment session, the third (T2) will be 12 weeks 
after the first assessment session. All measurements [see 
box 1] will be performed outside the physical therapy 
practice to assure that the observer will not recognise any 
of the study participants when they come to the physical 
therapy practice for their treatment. After this first assess­
ment, the patients will be randomly assigned to one of 
two groups: the intervention group or the control group. 
The patients in the control group will stay on the waiting 
list and will not receive any treatment. They are allowed to 
use over-the-counter painkillers during this 12-week 
period. After 6 weeks and 12 weeks, respectively, they will 
be examined by the same blinded observer. After 12 weeks 
they will receive the same physical therapy program as the 
experimental group [see Figure 1]. The initial trial ends 
after 12 weeks, but 6 months and 12 months after the start 
of the experimental intervention shoulder function of the 
subjects will be re-evaluated with the DASH-Dutch lan­
guage version.
In tervention
The patients in the intervention group will be treated by a 
physical therapist once a week for a maximum period of 
12 weeks. All participating physiotherapists are experi­
enced in treating patients with long-lasting shoulder 
symptoms and patients with MTrPs and myofascial pain, 
especially in the upper part of the body. They are trained 
and skilled in the identification of MTrPs and received a 
certification in manual trigger point therapy. The treat­
ment starts with inactivation of the active (pain produc­
ing) MTrPs by using manual techniques (compression on 
the trigger point, manual stretching of the trigger point 
area and the taut band) combined with "intermittent cold 
application by using ice-cubes followed by stretching the 
muscle" according to Travell [32] to further inactivate the 
MTrPs. Manual pressure will decrease the sensitivity of the 
painful nodule in the muscle while other massage tech­
nique will mobilize and stretch the contracted muscle 
fibres. The application of the ice-cubes has a desensitizing 
effect, and makes it easier to stretch shoulder muscles. 
Each treatment session will end with a heat application to 
increase the circulation of the involved muscles.
Patients will be advised to do stretching exercises and will 
be taught to perform these correctly by means of surface- 
electromyography-assisted stretching[33,34]. Further­
more they will be advised to perform relaxation exercises, 
and to applyheat (like a hot shower, hot packs) several 
times (at least twice) a day. If there is abnormal measura­
ble higher electromyographic activity in the upper trape­
zius muscle (measured by surface Electromyography 
(sEMG) using a Myomed 932 [Enraf Nonius, Delft, the 
Netherlands]) during standing and/or sitting [35], relaxa­
tion exercises will be performed using a portable myo- 
feedback device (Myotrac I, Thought Technology, Quebec, 
Canada). Abnormal sEMG activity is defined as a con­
stantly measured value above 1%-5% of the maximally 
voluntary contraction [36-39], which is in general above 
10 microvolt, during several minutes and the patient is 
not able to relax the muscle spontaneously or on request. 
Finally, all patients will receive ergonomic recommenda­
tions, andinstructions to assume and maintain "good" 
posture [40,41]. Manual high velocity thrust techniques 
of the cervical spine and the shoulder and dry needling are 
excluded from the treatment protocol, because not all par­
ticipating physical therapists are skilled to perform these 
techniques. The content of each session may vary as it 
depends on the findings during the first treatment session 
and the results of the previous treatment sessions. Thus, 
there are differences in the content of the individual treat­
ments, but within the limits of the treatment protocol.
S topru le
The treatment ceases when the patient is completely 
symptom-free or the patient and the therapist agree that
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F ig u re !
recruitment and experimental plan.
treatment will not further benefit the patient, although 
their participation in the study will prolong. If patients 
decide that they no longer wish to participate in the study 
they are free to withdraw from the study at any moment.
C on tro l o f in tervention  integrity
To enhance the integrity of this complex intervention, 
every week all participating physical therapists will discuss 
the content of each therapy session with the researcher 
(CB) without mentioning names or other information 
which will assure the blinding of the independent 
researcher (CB). After 6 and 12 weeks, the patients of the 
intervention group will interviewed about the content of 
the received treatment sessions to assure that all patients 
will be treated according to the protocol. If patients are 
not treated according to the protocol, they will be identi­
fied and participation may be discontinued.
E xp ec ta tio n s regarding trea tm ent outcom e
At the start of the trial (T0) both the patients and physical 
therapists will complete a questionnaire regarding the 
anticipated treatment outcome.
Setting
The study will be conducted in a physical therapy practice 
specialized in management of persons with musculoskel­
etal disorders of the neck, shoulder and arm. After ran­
domisation every patient assigned to the experimental 
group will be treated by the same physical therapist.
O bjectives
In the current study we will test the following hypothesis 
(H0).
A physical therapy treatment to inactivate MTrPs within a 
three months' period is as effective as a "wait and see" 
approach of patients with chronic shoulder complaints in 
a three month period.
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Population characteristics
* To identify potential confounding factors, demographic 
information for all subjects will be collected including 
age, gender, education, occupation, sports and leisure 
activities, duration of the complaints, and type of onset, 
among others.
* The Dutch language version of the RAND-36 item 
Health Survey will be used for base line characteristics of 
the study population. The RAND-36, which is almost 
identical to the MOS SF-36 [42], scores the functional sta­
tus and quality of life and is widely used for screening 
health status in medical, social and epidemiological 
research. The RAND-36 consists of 36 items divided into 
8 subscales concerning physical functioning, role limita­
tions due to physical health, role limitations due to emo­
tional problems, energy and fatigue, emotional well­
being, social functioning, pain, general health perception 
and health change. This questionnaire is considered to be 
a reliable instrument for comparing groups (internal con­
sistency Cronbach's alpha > 0.70). The test-retest stability 
is sufficient (0.58 -  0.82) and the questionnaire is respon­
sive when scoring after at least 4 weeks. The construct 
validity was estimated by comparing the RAND-36 with 
other Health questionnaires (like the Nottingham Health 
Profile [NHP] and the Groninger Activities Restriction 
Scale [GARS]. There are significant correlations between 
the subscales of the RAND-36 and the subscales of the 
NHP (correlation coefficient 0.42 -  0.69). The correlation 
coefficient between the subscale physical functioning and 
the GARS is 0.65. A higher score (maximum is 100 points) 
defines a more favourable health status.
* The Beck Depression Inventory (BDI) is used to discrim­
inate between patients with major depression and those 
without or with minor depressive feelings. The BDI is 
included because depression may be a confounding fac­
tor. The BDI is widely accepted and used in clinical and 
experimental research and its predictive value is rated as 
good. A BDI-score equally or higher than 21 indicates a 
major depression (specificity 78.4%) [43].
O utcom es
The following outcome parameters will be used:
Primary
The overall score of the DASH (Disability of Arm Shoulder 
and Hand) questionnaire -  Dutch language version will 
be used as the primary outcome measure. The DASH is a 
multidimensional (physical, emotional and social) 30- 
item self-report measure focussing on physical function 
pain and other symptoms. At least 27 of the 30 items must 
be completed for a score to be calculated. The assigned 
values for all completed responses are simply summed 
and averaged. This value is then transformed to a score out
of 100 by subtracting one and multiplying by 25. The 
transformation is done to make the score easier to com­
pare to other measures using a 0-100 scale. A higher score 
indicates greater disability.
, [(sum o f n  responses')-!]
DASH disability/sym pton score = —----------------- ----------— *-x 25
n
where n is equal to the number of completed responses.
Scoring is on a 5-point Likert scale from no difficulty (0 
points) to very difficult (5 points). The range of the total 
score is from 0 to 100, where 0 means no symptoms 
(pain, tingling, weakness or stiffness) and no difficulty in 
performing daily activities, while 100 means extreme, 
severe symptoms and unable to perform any daily activity. 
Content and face validity of the DASH were confirmed by 
a variety of experts of the American Academy of Orthopae­
dic Surgeons (AAOS), the council of Musculoskeletal Spe­
ciality Societies (COMSS) and the institute for Work and 
Health (Toronto, Ontario, Canada) throughout the devel­
opment process [44].
Its internal consistency was excellent (Cronbach's alpha = 
0.96) during field-testing. The test-retest reliability was 
excellent (ICC21 = 0.92 and 0.96) in two studies [45,46] 
and satisfactory in one study (Pearson 0.98 and kappa 
0.67). The minimal detectable Change (MDC) was calcu­
lated in a population of 172 patients with several upper 
limb disorders (Osteoarthritis, Carpal Tunnel syndrome, 
Rotator Cuff syndrome, Rheumatoid Arthritis and Tennis 
Elbow) [47]. The Minimal Detectable Change (MDC) var­
ied between 10.70 (at 90% confidence level) and 12.75 
(at 95% confidence level). The DASH demonstrated to be 
a responsive questionnaire.
The inter- and intra-observer reliability is good to excel­
lent (intra-observer reliability Pearson r = 0.96 to 0.98; 
ICC = 0.91 to 0.96; Inter-ob server agreement Cohen's 
kappa = 0.79).
The construct validity was estimated by comparing the 
DASH to several other questionnaires. The correlation 
with other instruments like the SPADI (Shoulder Pain and 
Disability Index) is good (Pearson's r = 0.82 to 0.88). The 
DASH questionnaire is one of the best among 16 other 
questionnaires for shoulder symptoms [48].
Secondary
An independent examiner will perform the following 
tests.
* The total number of shoulder muscles with MTrPs will 
be counted and compared to the baseline measurement 
findings.
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* Passive range of motion of the shoulder will be meas­
ured by an handheld digital inclinometer (The Saunders 
group Inc, Chaska, MN). The range of motion of the non­
painful shoulder will be used as reference [49,49,50]. 
Because the normal range of motion differs from one indi­
vidual to another, we focus on improvement of limited 
range of motion during the experiment (both experimen­
tal group and control group).
° For the measurement of passive external rotation, the 
patient is in a supine position, with the shoulder in 0° of 
abduction and rotation, the elbow flexed at 90° and the 
forearm in a neutral position. This position is defined as 
the position of 0°. The observer then performs external 
rotation until pain limits the range of motion or the 
extreme of the range is reached. The inclinometer is placed 
against the volar side of the forearm. This range of motion 
is recorded in degrees. The normal range of motion for 
external rotation is between 70° and 90°.
° For the measurement of passive glenohumeral abduc­
tion, the patient is seated upright, and the position of 0° 
is defined as the upper arm is in a neutral position. While 
palpating the lower angle of the scapula with the thumb, 
the examiner elevates the upper arm of the patient until 
the scapula begins to rotate or pain limits further motion. 
The inclinometer is placed against the lateral side of the 
upper arm near the elbow. The range of motion is 
recorded in degrees. The normal range of motion is 90°.
° For the measurement of passive elevation (through flex­
ion), the patient is in the supine position with the arm 
along the side. This position is defined as the position of
T a b le  ! :  O v e rv ie w  o f  va ria b les
0°. The observer than performs elevation until pain limits 
the range of motion or the extreme of the range is reached. 
Then the inclinometer is placed against the medial side of 
the upper arm near the elbow. The range of motion is 
recorded in degrees. The normal range of motion is 
between 165° and 180°
° For the measurement of internal rotation the patient is 
in a prone position. The shoulder is 90° abduction, and 
the forearm is in neutral position. This position is defined 
as the position of 0°. The observer than performs internal 
rotation until pain limits the range of motion or the 
extreme of the range is reached. The sensor is placed 
against the volar side of the forearm. The normal range of 
motion is 70°
° For the measurement of horizontal adduction the 
patient is in a supine position. The arm is in 90° abduc­
tion. This position is defined as the position of 0°. The 
observer performs adduction, while the arm stays in the 
vertical plane, until pain limits the range of motion or the 
extreme of the range is reached. The normal range of 
motion is 135°
* Finally the total number of treatment sessions will be 
counted. This is done by an assistant, who is not involved 
in the study by using the administration-software of the 
practice [see Table 1].
Sam ple size
The initial sample size is based on the assumption that the 
overall score of the primary outcome measure DASH 
shows a mean improvement of 15 points [SD = 22] [51].
Variable T0 Baseline T ! A fte r 6 wk T2 A fte r 12 w k Measured by
A ge* X Interview
G ender* X Interview
W o rk X Interview
D o m in a n t side a ffe c te d X Interview
D u ra tio n  o f  th e  co m p la in ts * X Interview
D A S H  DLV X X X Questionnaire
Use o f m e d ica tion X X X Interview
Use o f o th e r  th e ra p y X X X Interview
W o rk  % X X X Interview
Im p ro ve m e n t (percentage o f perceived im provem ent) X X Interview
N u m b e r o f  in vo lved  m uscles X X X Assessment
N o . o f  t re a tm e n t sessions X Assessment
H e a lth  s ta tus  fo r  baseline comparison X R A N D -36 DLV
E xistence an d  se ve rity  o f  sym p to m s o f  depression X Beck Depression Inventory
S hou ld e r Passive R O M X X X G on iom etry
• flexion X X X
• abduction X X X
• external rota tion X X X
• internal ro ta tion X X X
• cross body adduction X X X
*Age, gender and duration of the complaints seem to  be important prognostic variables [53].
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To test the null hypothesis of equality of treatment at a  = 
.05 with 90% power and assuming a uniform dropout rate 
of 5%, it was calculated that 52 patients in each group 
would be sufficient.
Random ization
After inclusion the patients will be randomly assigned to 
either the intervention group or the "wait and see" group. 
The randomisation will be performed by an assistant not 
otherwise involved in the study by generating random 
numbers using computer software. Stratification or block­
ing strategies will not be used.
In form ed consent
The patients will be informed about the study prior to the 
first assessment and will be asked to give written informed 
consent.
Blinding
Blinding of the patients or the physical therapists, who are 
involved in the treatment, is impossible due to the treat­
ment characteristics.
An independent observer will collect baseline data and 
outcome data. The independent observer is blinded. The 
successfulness of the blinding procedure will be evaluated 
by asking the observer to which group she believes the 
subjects belong.
Sta tistica l analysis
For comparisons of prognostic variables on baseline we 
will use the Student's t test for continuous variables with 
normal distribution and the chi-square test for categorical 
variables or continuous variables with non-normal distri- 
bution[52]. For the overall score of the DASH (primary 
outcome measure) we will use the unpaired t-test for nor­
mally distributed data or Mann-Whitney Rank Sum-test 
for non-normally distributed data to assess the difference 
between the two groups after the treatments. Regression 
analyses will be used to include prognostic factors, such as 
the baseline scores like age, gender and duration of the 
complaints, in the analyses. All significance levels will be 
set at p < 0.05. All data will be analysed primarily accord­
ing to intention-to-treat principle. We will use Sigmastat 
3.11 and Systat 12 for windows (Systat Inc. Richmond, 
California, USA) for the statistical analyses.
Discussion
Since there is little evidence for the efficacy of physical 
therapy interventions in some shoulder disorders, there is 
a need for further research. Therefore we will perform a 
randomised clinical trial dealing with the effect of physi­
cal therapy interventions aimed to inactivate MTrPs on 
pain and impairment in shoulder function in a popula­
tion of chronic a-traumatic shoulder patients. To the best
of our knowledge, few studies of the efficacy of MTrP ther­
apy are published. We choose for an intervention strategy 
that best reflects daily practice. We excluded manual high 
velocity thrust techniques and intramuscular MTrP release 
by dry needling, because these interventions are not com­
monly used by Dutch physical therapists and not all par­
ticipating therapists were skilled to perform these 
techniques at the beginning of the study. In most physical 
therapy interventions, blinding of the patient and the 
therapist is not possible. The observers will be blinded for 
the allocation procedure. The results of this trial will be 
presented as soon as they are available.
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